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Alzheimer’s  disease  affects  nearly  36.5 million  people  worldwide,  and  acetylcholinesterase  inhibition  is
currently  considered  the  main  therapeutic  strategy  against  it.  Seaweed  biodiversity  in  Brazil  represents
one  of the  most  important  sources  of  biologically  active  compounds  for applications  in  phytother-
apy.  Accordingly,  this  study  aimed  to carry  out  a quantitative  and  qualitative  assessment  of Hypnea
musciformis  (Wulfen)  J.V. Lamouroux,  Ochtodes  secundiramea  (Montagne)  M.A.  Howe,  and  Pterocladiellacetylcholinesterase inhibition
alogenated monoterpenes
ypnea
chtodes
terocladiella
hodophyta
capillacea  (S.G.  Gmelin)  Santelices  & Hommersand  (Rhodophyta)  in order  to  determine  the  AChE  effects
from  their  extracts.  As  a matter  of fact,  the  O. secundiramea  extract  showed  48% acetylcholinesterase
inhibition  at  400 g/ml.  The  chemical  composition  of  the  bioactive  fraction  was  determined  by  gas
chromatography–mass  spectrometry  (GC–MS);  this  fraction  is  solely  composed  of halogenated  monoter-
penes,  therefore  allowing  assignment  of  acetylcholinesterase  inhibition  activity  to  them.
© 2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Alzheimer’s disease (AD) is a chronic neurodegenerative disor-
er characterized by a loss of basal forebrain cholinergic neurons
nd reduced level of the neurotransmitter acetylcholine (ACh)
Alzheimer’s Association, 2014). AD affects up to 5% of people over
5 years of age, rising to 20% of those aged over 80 years, suggest-
ng the importance of treating this disease based upon increased
ife expectancy, particularly in developed countries worldwide.
peciﬁcally, estimates show that 27.7 up to 35 million people were
ffected by this disease from 2005 through 2010, respectively. In
his same survey, it was found that treatment costs increased from
56 USD billion to 604 billion (Wimoa  et al., 2007, 2013).
Control over AD is achieved by extending the action of acetyl-
holine (ACh) via acetylcholinesterase inhibition (AChEI). Current
rugs exhibit two action mechanisms, either prosthetic or acid-
ransferring. Prosthetic inhibitors have an afﬁnity for the anionic
ite of acetylcholinesterase and prevent acetylcholine from acces-
ing it (competitive inhibitors). Acid-transferring inhibitors react
∗ Corresponding author.
E-mail: nyokoya@pq.cnpq.br (N.S. Yokoya).
http://dx.doi.org/10.1016/j.bjp.2015.09.003
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorawith the enzyme and form an intermediate compound. Depend-
ing on the stability of this product, the effects could be short-term
and reversible or long-acting and irreversible (Nair and Hunter,
2004).
The current drugs used against AD are plant-derived alkaloids:
rivastigmine and galantamine. These drugs are AChEIs and can be
used to treat early and moderate stages of AD by increasing the
endogenous levels of acetylcholine to boost cholinergic neurotrans-
mission (McGleenon et al., 1999). Although these drugs display
some undesirable side effects, such as hepatotoxicity and gastroin-
testinal disorder, there is a growing interest in ﬁnding new AChE
inhibitors from natural sources, but with few off-target effects
(Rhee et al., 1997).
Marine organisms have a high chemical diversity of ecologically
active substances with protective functions against predators, bio-
foulers and epiphytes, as well as against constant changes in abiotic
conditions tolerated by algae in the marine coastal environment
(Amsler, 2008; Ferreira et al., 2012; Mesko et al., 2015). Such diver-
sity provides a useful resource for the discovery of novel bioactive
carbon compounds, many of them with potential applications in the
pharmaceutical, nutraceutical, and agricultural ﬁelds (Smit, 2004;
Cardozo et al., 2006; Gressler et al., 2011a, 2011b; Torres et al.,
2014).
 Ltda. All rights reserved.
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Seaweed extracts have been tested against ACh enzyme with
uccessful results (Natarajan et al., 2009). As such, seaweeds rep-
esent a promising group of species for developing new marine
atural products based on the ease of obtaining biomass by per-
orming cultures for the exploitation of bioactive compounds
Baweja et al., 2009 and therefore contributing to the conservation
f natural populations (Yokoya and Yoneshigue-Valentin, 2011).
Hence, motivated by the economic and social impact of AD, this
tudy was aimed at testing the qualitative and quantitative AChEI
ctivity of organic extracts obtained from three Brazilian red algae.
he chemical composition of the bioactive fractions was investi-
ated by gas chromatography–mass spectrometry (GC–MS).
aterials and methods
lgal material and extraction
Two hundred grams (fresh weight; equivalent to thirty indi-
iduals of each species) of Hypnea musciformis (Wulfen) in J.V.
amouroux, Ochtodes secundiramea (Montagne) M.A. Howe and Pte-
ocladiella capillacea (S.G. Gmelin) Santelices & Hommersand were
ollected from a lateritic reef at Manguinhos Beach (20◦11′12′′ S,
0◦11′24′′ W)  in the municipality of Serra, Espírito Santo State,
razil. After collection, seaweed biomass was cleaned and immedi-
tely transported to the laboratory in dark plastic ﬂasks containing
ltered seawater maintained at 22 ◦C by means of thermal pack-
ging. Furthermore, the seaweeds were properly identiﬁed and
eposited in the Herbarium VIES, Universidade Federal do Espírito
anto, under voucher numbers 18.853, 18.854 and 18.855, cor-
esponding to H. musciformis, O. secundiramea,  and P. capillacea,
espectively.
The freshly cleaned seaweeds were weighed and then imme-
iately extracted by using 10 ml  of dichloromethane/methanol
DCM/MeOH) (2:1, v/v) per 1 g of seaweed (Machado et al., 2014a).
he material was maintained in a dark room at 20 ◦C for one week,
nd then the extracts were ﬁltered through a Whatman No. 5 ﬁl-
er paper and concentrated by under low pressure. The extraction
ield was calculated for each algal sample. All chemicals used were
f analytical grade (Merck, Darmstadt, Germany).
nhibitory activity of acetylcholinesterase (AChEI)
ualitative evaluation by autographic assay
The AChEI activity of DCM/MeOH crude extract was detected
y using a thin-layer chromatography (TLC) autographic assay as
reviously described (Marston et al., 2002). Aliquots of 100 g of
ach dried seaweed extract and 0.3 g of physostigmine (Sigma,
sed as positive control) were dissolved, spotted on TLC layers
Silica gel 60 F254, 10 × 10 cm,  layer thickness 0.2 mm,  E. Merck,
ermany), which were developed with mobile phase hexane:ethyl
cetate:methanol (2:7:1 v/v/v), and then dried. Next, the plates
ere sprayed with the enzyme solution (6.66 U/ml) (Electric eel
ChE type V, product no. C 2888, 1000 U – Sigma–Aldrich), thor-
ughly dried, and incubated in a humid atmosphere at 37 ◦C for
0 min. Afterwards, the plates were sprayed with 0.25% of 1-
aphthylacetate in ethanol (5 ml)  plus 0.25% of aqueous Fast Blue
 salt solution (20 ml). The spots corresponding to potential acetyl-
holinesterase inhibitors were identiﬁed as clear zones against a
urple background.
Retention factor values (Rf) of bioactive compounds were
etermined and employed for their preparative scale isolation
y thin-layer chromatography (20 cm × 20 cm,  layer thickness
.5 mm,  60 F 254, Sigma–Aldrich). Extract samples of 80 mg  were
pplied on preparative plates which were developed under iden-
ical conditions to those used at analytical scale essays. Afterarmacognosia 25 (2015) 657–662
elution, the AChE-positive regions were removed from the plates
and extracted with DCM/MeOH (90:10 v/v).
Quantitative evaluation by microplate assay
AChE activity was  measured using a modiﬁed 96-well
microplate assay based on Ellman’s method (Ellman et al., 1961, as
modiﬁed by Rhee et al., 2001). Such extremely sensitive method
is based on measuring thiocholine production when acetylthio-
choline is hydrolyzed. This is accomplished by the continuous
reaction of thiol with 5,5′-dithiobis(2-nitrobenzoic acid). Solutions:
A. Tris/HCl 50 mM,  pH 8; B. Tris/HCl 50 mM,  pH 8, with 0.1% bovine
albumin fraction V; C. Tris/HCl 50 mM,  pH 8, with NaCl (0.1 M)  and
MgCl2·6H2O (0.02 M).
To each well of a 96-well microplate, 25 l acetylthiocholine
iodide (15 M),  125 l of 5,5′-dithiobis (2-nitrobenzoic acid) in
solution C (3 M DTNB or Ellman’s reagent), 50 l of solution
B, 25 l of seaweed extract dissolved in MeOH and diluted in
solution A at concentrations of 1.56, 12.5, 25, 50, 100, 200 and
400 g/ml were added. The absorbance was  measured at 405 nm
for 30 sec. After 25 l of the enzyme AChE (0.22 U/ml) was  added,
the absorbance was again read every 5 min  of incubation for four
times. The percentage of AChE inhibition was calculated by com-
paring the reaction rates of samples to the negative control (10%
MeOH in solution A, considering 100% as the total activity of AChE).
Physostigmine was used as standard at concentrations ranging
from 1.56 to 400 g/ml. A BioTek ELISA reader (PowerWaveTM HT
Microplate Reader and KC4TM software) was used to determine
reaction rates. This analysis was carried out in triplicate (n = 3) to
calculate the mean and standard deviation.
CG–MS analysis of bioactive fraction obtained from O.
secundiramea extract
Currently, different strategies have been reported in the litera-
ture in order to estimate algal compounds applying CGMS (Gressler
et al., 2009). The bioactive fraction obtained from O. secundi-
ramea was analyzed by a gas chromatograph-mass spectrometer
(GCMS-QP2010 Plus, Shimadzu, Japan) provided with a HP-5MS
column (30 m × 0.25 mm × 0.1 m).  The samples were injected in
split mode at 220 ◦C, and the transfer line was set to 240 ◦C. Helium
(99.999%) was used as the carrier gas at a constant ﬂow rate of
1 ml/min. A linear oven temperature program was employed. The
temperature was ramped from 60 to 260 ◦C at a rate of 3 ◦C/min
and then held at 260 ◦C for 40 min. Detection was  performed in
full scan mode, mass-to-charge ratio (m/z) 50–650. Electron impact
ionization was employed (collision energy = 70 eV), and the mass
spectrometer ion source was maintained at 240 ◦C. Compounds
were identiﬁed by their GC retention times and mass spectra
(NIST08 Mass Spectral Library and literature data). The area of each
peak in the total ion chromatogram was integrated.
Results and discussion
Fig. 1 shows the qualitative results of the autographic assay
of acetylcholinesterase inhibition activity (AChEI), and Table 1
displays the fresh seaweed biomass weights, dried extract and
extraction yield along with AChEI data of the autographic assay:
Rf and bioactive compound intensity.
The AChEI activity of plant extracts is classiﬁed according to
Vinutha et al. (2007) as potent inhibitors (greater than 50% inhibi-
tion), moderate inhibitors (30–50% inhibition) and weak inhibitors
(below 30% inhibition). According to this classiﬁcation, the extracts
of O. secundiramea have moderate activity (48.59 ± 0.8%), while H.
musciformis and P. capillacea extracts have weak activity (7.21 and
5.38%, respectively), at a higher concentration (Fig. 2).
As described in the literature, seaweed extracts exhibit poor
anti-AChE activity, with IC50 ranging from 2.6 to 10 mg/ml, far
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Table  1
Seaweed biomass, extract dry weights, extraction yields and autographic acetylcholinesterase inhibition (AChEI) assay results.
Seaweed Fresh weight (g) Dried extracts (g) Yield (%) Rf of AChEI compounds Intensity of AChEI activity
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sHypnea musciformis 200 1.82 
Pterocladiella capillacea 200 0.4 
Ochtodes secundiramea 200 2.82 
maller than that showed by O. secundiramea extract. The Ecklonia
tolonifera ethanolic extract (IC50 100 g/ml) and Ishige okamu-
ae methanolic and ethanolic extracts (IC50 163.07 M and IC50
37.25 M,  respectively) are the only exceptions (Stirk et al.,
007; Yoon et al., 2008; Kartal et al., 2009; Suganthy et al., 2010;
angestuti and Kim, 2011).
DCM/MeOH extract (15 mg)  were employed in the fraction-
tion carried out under the same conditions as those described for
he analytical TLC experiments. The bioactive fraction (2.45 mg;  Rf
.62–0.71), which corresponded to 16.3% of the crude extract, was
nalyzed by GC–MS; the resulting data are shown in Table 2 and
ig. 3.
The active fraction compounds present the typical fragmenta-
ion losses related to chlorine and bromine losses (respectively, 35
nd 79 m/z), as clearly observed on the mass spectra. The char-
cteristic multiplicity of halogen isotope abundance (35Cl:37Cl –
5.2:24.8% and 79Br:81Br – 50:50%) was observed in their molecu-
ar ions. As reported in numerous structural studies, both magnetic
esonance spectra (13C NMR) (McConnell and Fenical, 1978; Paul
t al., 1980; Naylor et al., 1983) and mass fragmentation (Polzin and
orrer, 2003; Barahona and Rorrer, 2003) have played a key role
n the structural characterization of halogenated monoterpenes
Maliakal et al., 2001; Machado et al., 2014a).However, it can also be observed in the total ion chromatogram
n which the peak 8 corresponds to the majority compound that has
/z value 329. Its mass spectra showed fragment ions at m/z 294,
ndicative of chlorine loss (M+−Cl), and at m/z 213 and m/z 133,
PC 1 2 3
ig. 1. TLC qualitative acetylcholinesterase inhibition (AChEI) assay. PC: positive
ontrol, physostigmine (0.03 g). DCM/MeOH extracts (100 g) of (1) Hypnea mus-
iformis,  (2) Pterocladiella capillacea and (3) Ochtodes secundiramea.  TLC elution
ystem: hexane:ethyl acetate:methanol (2:7:1 v/v/v).0.91 0.01 Low
0.2 0.65 Low
1.41 0.62–0.71 Strong
which are characteristic of bromine and chlorine losses (M+−BrCl
and M+−Br2Cl), respectively. The ions at m/z  93 and at m/z  133
are observed in the fragmentation of acyclic monoterpenes. This
compound (C10H15Br2Cl) has been identiﬁed as (E)-1,2-dibromo-
3-chloromethylene-7-methyloct-6-ene, by comparison of its mass
spectrum data with those found in the literature, and allowed
its discrimination among isomeric compounds (Coll and Wright,
1987).
The compounds 1, 2, 7, 9, and 10 could also be identiﬁed by
comparing the data collected from their mass spectra (Table 2)
to the literature ones. Compounds 1 (C10H16), 2 (C10H15OBr), 7
(C10H14Br3Cl), 9 (C10H15Br2ClO), and 10 (C10H14Br2Cl2) are named
as 7-methyl-3-methyleneocta-1,6-diene (myrcene) (Polzin and
Rorrer, 2003); 6(S*)-bromoocta-1,3(8)-dien-4(R*)-ol (Paul et al.,
1980); 2-chloro-1,6(S*),8-tribromo-3-(8)(Z)-ochtodene (Gerwick,
1984); 7-chloro-4,8,dibromo-1-ethyl-3,3-dimethyl-6-hidroxi-7,8-
cyclohexene (Naylor et al., 1983); (3R*,4S*,5E)-4,8-dibromo-3,7-
dichloro-3,7-dimethylocta-1,5-diene (Coll et al., 1988), respec-
tively.
The compound 2 (C10H15OBr) [6(S*) bromoocto-1,3(8) dien-
4(R)-ol] was  prepared by synthesis and the remaining ones
were not properly identiﬁed due to insufﬁcient data: the
compounds 3 (C10H14Br2), 4 (C10H14BrCl, and 6 (C10H13Br2Cl)
are known as 3,7-dibromo-myrcene (Barahona and Rorrer,
2003); (Z)-10-bromo-7-chloro myrcene (Burreson et al., 1975);
and (Z)-10-chloro-3,7-dibromo-myrcene (Gerwick, 1984), respec-
tively.
Mass spectral fragmentation of compound 5 suggests an aro-
matic structure due to a sequence of peaks at m/z  91, 79, 65, 41;
however the great number of isomers having the same structural
formula did not allow the compound identiﬁcation.Currently, monoterpenes are the second major class of natu-
ral metabolites with AChEI activity, surpassed only by alkaloids
(Barbosa-Filho et al., 2006), and extracts containing mixtures of
100
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Fig. 2. Quantitative evaluation of acetylcholinesterase activity (AChE) of the
DCM/MeOH algal extracts (1.56, 12.5, 25, 50, 100, 200 and 400 g/ml), compared to
the standard physostigmine. Mean and standard deviation (n = 3).
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Table  2
GC–MS data from bioactive fraction (Rf 0.62–0.71) obtained from preparative TLC carried out with Ochtodes secundiramea extract.
Peak Retention time (min) (%) Area Molecular mass
m/z
M+−halogen Main mass fragments
(intensity of signal)
Molecular formula Reference
1 18.036 5.23 136 – 41(50) 69(100) 78,
81(20)
93(90) 107(25) 119(50)
135(80) 136 (trace)
C10H16 Polzin and Rorrer (2003)
2 30.913 11.41 229; 230 149 (M+−Br) 41(40) 53(40) 79(70)
91(100)
105 (95) 122(85)
133(55)
149(80) 185(30) 229,
230(70)
C10H15OBr Paul et al. (1980)
3 31.636 2.82 292; 294; 296 213(M+−Br)
133(M+ -Br2)
41(15) 65(15) 77(20)
93(50) 105(40) 118(50)
133(100)
C10H14Br2 Barahona and Rorrer (2003)
4 36.215 3.09 248; 249; 251 214(M+−Cl)
167(M+−Br)
133 (M+−BrCl)
44(60) 51(10) 65(20)
77(30)
93(100) 105(40)
117(60)
133(60)167 169(20)
212
213(5)
C10H14BrCl Burreson et al. (1975)
5 39.856 13.82 311 229(M+−Br)
149 (M+−Br2)
41(50) 55 (50) 65(40)
79(80)
91(100) 105(40)
118(60)
133(95) 149(25)
229(20)
C10H12OBr2 Paul et al. (1980)
6 40.682 5.81 323;325 217 (M+−BrCl)
167 (M+−Br2)
133(M+−Br2Cl)
41(40) 65(30) 77(50)
93(95)
105(50) 117(60)
133(100)
167(40) 217(40)
C10H13Br2Cl Polzin et al. (2003)
7 43.298 13.81 408; 410 375 (M+−Cl)
329 (M+−Br)
249 (M+−Br2)
167(M+−Br3)
133 (M+−Br3Cl)
41(10) 77(40) 91(50)
105(30)
117(50) 133(100) 167
197 213 249 294 329
375 (5)
C10H14Br3Cl Gerwick, 1984
8 45.273 30.13 328; 330; 332 294 (M+−BrCl)
249 (M+−Br)
213 (M+−BrCl)
167 (M+−Br2)
133 (M+−Br2Cl)
69(15) 77(40) 93(50)
105(40)
133(100) 167(50)
213(5)
249(5) 294(3)
C10H15Br2Cl Coll and Wright (1987)
9 46.900 2.52 344; 346; 348 310 (M+−Cl)
267 (M+−Br)
229 (M+−BrCl)
185(M+−Br2)
147 (M+−Br2Cl)
65(20) 77(30) 91(100)
105(40) 117(60)
133(60);
147(15) 185, 187 (20)
197, 199(5) 212, 213(5)
229(10);
267 269(5)
285 287 (5);
310 311(5)
C10H15Br2ClO Naylor et al. (1983)
10 47.972 18.36 360; 362; 364 329 (M+−Cl)
294(M+−Cl2)
284 (M+−Br2)
247 (M+−BrCl)
+ )
)
2)
77(40) 91(50) 105 (30)
117(50) 133(100)
167(80)
213(40) 247(15)
C10H14Br2Cl2 Coll et al. (1988)
m
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c213 (M −BrCl2
167 (M+−Br2Cl
133 (M+−Br2Cl
onoterpenes generally display high AChEI. They are reversible
ompetitive inhibitors of acetylcholinenesterase (Keane and Ryan,
999) and such effect is attributed to the combined actions of
hese multifunctional compounds which can exert their activities
hrough different mechanisms (Koroch et al., 2007). These obser-
ations are in accordance with the present study documenting
he potential AChEI of an O. secundiramea extract containing halo-
enated monoterpenes.
Brominated monoterpenes are formed via reactions catalyzed
y enzymes capable of generating nucleophilic halide anions, elec-
rophilic hypohalite species, or halogen radicals, promoting the
ubstitution of hydrogen atoms for halogens in aliphatic hydro-
arbons (Moore, 2006; Hillwig and Liu, 2014). Their AChEI can284(20)
294(15) 329 (5)
result from the easy displacement of bromine by neutral or anionic
nucleophiles which could then be removed by elimination reac-
tions (Dagani et al., 2014).
Whereas the toxicity, or side effects, of alkaloids, widely used
as a source of potential acetycholinesterase inhibitors, is a draw-
back in Alzheimer’s disease treatment, O. secundiramea extract
showed, in preliminary trials, no cytotoxicity or mutagenic activ-
ities at concentrations twice as much those tested in the present
study (Machado et al., 2014b).The results presented herewith provided evidence to corrob-
orate the therapeutic potential of O. secundiramea monoterpenes
based upon their moderate AChEI activity in combination with
minimal off-target effects.
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